newsfilter
← Latest News
GlobeNewswire·

Kyverna Therapeutics to Present at the J.P. Morgan 2026 Healthcare Conference

EMERYVILLE, Calif., Jan. 05, 2026 (GLOBE NEWSWIRE) -- Kyverna Therapeutics, Inc. ((Kyverna, NASDAQ:KYTX), a clinical-stage biopharmaceutical company focused on developing cell therapies for patients with autoimmune